© 2011 dannemann siemsen. todos os direitos reservados. biotech ip issues in brazil gustavo morais...
TRANSCRIPT
© 2011 Dannemann Siemsen. Todos os direitos reservados.
Biotech IP issues in Brazil
Gustavo Morais
May 2011
Gustavo Morais
May 2011
© 2011 Dannemann Siemsen. Todos os direitos reservados.
2
Brazil - Patents Changing scenario
Brazil - Patents Changing scenario
No pharmaceutical and agrochemical patents (products) as of 1945 (processes excluded as of 1969)
No provisions concerning living matter
TRIPS - Jan 1, 1995
IP Law Nº 9,279 of May 14, 1996 (IPL)
No pharmaceutical and agrochemical patents (products) as of 1945 (processes excluded as of 1969)
No provisions concerning living matter
TRIPS - Jan 1, 1995
IP Law Nº 9,279 of May 14, 1996 (IPL)
© 2011 Dannemann Siemsen. Todos os direitos reservados.
3
Agrochemical patents
Patentability of GM microorganisms and of several inventions involving living matter
Waive of transition periods
Pipeline patents
Criteria for damage calculation
Agrochemical patents
Patentability of GM microorganisms and of several inventions involving living matter
Waive of transition periods
Pipeline patents
Criteria for damage calculation
© 2011 Dannemann Siemsen. Todos os direitos reservados.
4
Preliminary injunctions
Civil and criminal penalties against infringers
Infringement by equivalency
Patent term: 20 years as of filing or 10 years from grant, whichever expires later
Problem: ANVISA’s intervention – pharmaceutical products and processes
Preliminary injunctions
Civil and criminal penalties against infringers
Infringement by equivalency
Patent term: 20 years as of filing or 10 years from grant, whichever expires later
Problem: ANVISA’s intervention – pharmaceutical products and processes
© 2011 Dannemann Siemsen. Todos os direitos reservados.
5
Patentability criteria Novelty Inventive step Industrial applicability
Enablement Brazil not a member of Budapest Treaty Biological material may be filed in any IDA
Patentability criteria Novelty Inventive step Industrial applicability
Enablement Brazil not a member of Budapest Treaty Biological material may be filed in any IDA
Patent basicsPatent basics
© 2011 Dannemann Siemsen. Todos os direitos reservados.
6
PatentsSubject matter
PatentsSubject matter
Not patentable:
Living beings and parts thereof, including cells even if modified TRIPS 27.3(b) allows exclusion of patentability only “plants
and animals”
Naturally occurring biological material (even if isolated, purified or synthesized) and natural biologic processes
Not patentable:
Living beings and parts thereof, including cells even if modified TRIPS 27.3(b) allows exclusion of patentability only “plants
and animals”
Naturally occurring biological material (even if isolated, purified or synthesized) and natural biologic processes
© 2011 Dannemann Siemsen. Todos os direitos reservados.
7
Not patentable:
Therapeutic, surgical and diagnostic methods applied to human or animal bodies
Discoveries as opposed to inventions
Genetic Use Restriction Technologies (GURTs) Crime to use, sell, register, patent and license
Not patentable:
Therapeutic, surgical and diagnostic methods applied to human or animal bodies
Discoveries as opposed to inventions
Genetic Use Restriction Technologies (GURTs) Crime to use, sell, register, patent and license
© 2011 Dannemann Siemsen. Todos os direitos reservados.
8
Patentable:
Microorganisms genetically modified through human intervention
Modified DNA/RNA sequences and genes Considered as chemical compounds
Any process of genome modification
Patentable:
Microorganisms genetically modified through human intervention
Modified DNA/RNA sequences and genes Considered as chemical compounds
Any process of genome modification
© 2011 Dannemann Siemsen. Todos os direitos reservados.
9
Patentable:
Chemical compositions characterized by its intrinsic features, even if including naturally occurring biological material
Processes for obtaining, isolating, modifying, manufacturing and using biological materials and living beings Except humans (biosafety law)
Patentable:
Chemical compositions characterized by its intrinsic features, even if including naturally occurring biological material
Processes for obtaining, isolating, modifying, manufacturing and using biological materials and living beings Except humans (biosafety law)
© 2011 Dannemann Siemsen. Todos os direitos reservados.
10
Polynucleotides epolypeptides
Polynucleotides epolypeptides
Allowable claims:
DNA sequence characterized by presenting ... Sequence DNA sequence characterized by being Seq. ID nº Recombinant protein characterized by being Seq. ID nº
Not allowable claims:
DNA sequence characterized by codifying protein X Protein characterized by presenting activity Y
Allowable claims:
DNA sequence characterized by presenting ... Sequence DNA sequence characterized by being Seq. ID nº Recombinant protein characterized by being Seq. ID nº
Not allowable claims:
DNA sequence characterized by codifying protein X Protein characterized by presenting activity Y
© 2011 Dannemann Siemsen. Todos os direitos reservados.
11
Polynucleotides epolypeptides
Polynucleotides epolypeptides
Naturally occuring biological material – not patentable
A composition including such material may be if its only distinctive feature is not the presence of of the material
Purifying and isolation methods - patentable
Naturally occuring biological material – not patentable
A composition including such material may be if its only distinctive feature is not the presence of of the material
Purifying and isolation methods - patentable
© 2011 Dannemann Siemsen. Todos os direitos reservados.
12
AntibodiesAntibodies
Patentable
Monoclonal antibody characterized by its hybridoma
Not patentable
Polyclonal antibodies since they considered a by-product of natural biological processes
Patentable
Monoclonal antibody characterized by its hybridoma
Not patentable
Polyclonal antibodies since they considered a by-product of natural biological processes
© 2011 Dannemann Siemsen. Todos os direitos reservados.
13
Methods of treatment and diagnosisMethods of treatment and diagnosis
Not patentable per se Swiss type claims
Patentable - methods of obtaining data outside the human or animal body such as measuring blood pressure, X-ray examination, hemograms, etc.
Not patentable - methods of diagnosis performed in the human or animal body (e.g, to determine an allergy)
Not patentable per se Swiss type claims
Patentable - methods of obtaining data outside the human or animal body such as measuring blood pressure, X-ray examination, hemograms, etc.
Not patentable - methods of diagnosis performed in the human or animal body (e.g, to determine an allergy)
© 2011 Dannemann Siemsen. Todos os direitos reservados.
14
Stem cellsStem cells
Not patentable per se
Patentable - methods of obtaining stem cells and using them, except if method of treatment or diagnosis
Not patentable per se
Patentable - methods of obtaining stem cells and using them, except if method of treatment or diagnosis
© 2011 Dannemann Siemsen. Todos os direitos reservados.
15
IP in agricultureIP in agriculture
Plants not patentable, even if GM Only the genes Plant variety protection
Examples of allowable claims:
Method of pest or weed control using certain agrochemicals and/or plants
Process to confer to plants resistance to XYZ pesticide
Plants not patentable, even if GM Only the genes Plant variety protection
Examples of allowable claims:
Method of pest or weed control using certain agrochemicals and/or plants
Process to confer to plants resistance to XYZ pesticide
© 2011 Dannemann Siemsen. Todos os direitos reservados.
16
Access to Brazilian biodiversityAccess to Brazilian biodiversity
Authorization to access GRs and associated TK
Indication of source in patent applications filed as of 2007
Components of genetic heritage x biological resources
Recent PTO office actions and fines imposed on companies
Authorization to access GRs and associated TK
Indication of source in patent applications filed as of 2007
Components of genetic heritage x biological resources
Recent PTO office actions and fines imposed on companies